Results 131 to 140 of about 11,777 (217)

The P2Y13 receptor-mediated microglial morphological transformation through the p38MAPK signaling pathway contributes to central sensitization in a murine model of chronic migraine. [PDF]

J Headache Pain
Yang Y, Sun S, Qin P, Sun Y, Li H, Wang D, He X, Ge Z, Fan Z, Zhang J, Sun S.   +10 more
europepmc   +1 more source

Smooth muscle relaxants for intrauterine device placement: A systematic review. [PDF]

Contraception
Snyder EM, Krishna G, Zapata LB, Nguyen AT, Whiteman MK, Curtis KM.   +5 more
europepmc   +1 more source

Contrast-induced delayed coronary vasospasm and optical coherence tomography-confirmed plaque rupture-induced ST-segment elevation myocardial infarction: a case series of Kounis syndrome. [PDF]

J Geriatr Cardiol
Xu Y, Wang YP, Fan YY, Fu W, Zu LY.
europepmc   +1 more source

Arrhythmogenic Isolated Right Coronary Vasospasm. [PDF]

JACC Case Rep
Kendall MR, Tilkens B, Solis J, Kieu A, Jan MF, Haddadian B.   +5 more
europepmc   +1 more source

Report on Analysis of Drugs by Infrared Spectrophotometry: Atropine Sulfate Tablets and Nitroglycerine Tablets

Journal of AOAC INTERNATIONAL, 1958
openaire   +1 more source

Effects of warm needle acupuncture on behavioral pain threshold in a rat model of migraine. [PDF]

Front Neurol
Liu Q, Qin X, Luo C, Zhao Z, Xie W, Du X, Qin X.   +6 more
europepmc   +1 more source

BIOEQUIVALENCE COMPARISON OF TWO DRUG-IN-ADHESIVE TRANSDERMAL NITROGLYCERIN PATCHES

American Journal of Therapeutics, 1996
Plasma concentrations of nitroglycerin, 1,2-dinitroglycerin and 1,3-dinitroglycerin in 50 healthy male subjects who received single 24-h applications of two 0.6 mg/h drug-in-adhesive transdermal nitroglycerin patch formulations were compared for the purpose of establishing bioequivalence.
Lester I., Harrison, Dianna J., Riedel, Jane H., Machacek, Jan K., Crowley, Charlene M., Kanniainen, J. Adele, Hoglin, Tom S., Robison, Jeff M., Zumhofe   +7 more
openaire   +3 more sources

Transdermal nitroglycerin as a step 3 antihypertensive drug

Clinical Pharmacology and Therapeutics, 1986
The antihypertensive effect of transdermal nitroglycerin was tested in 11 men with hypertension (mean age 60 years) whose diastolic blood pressure exceeded 90 mm Hg while receiving a diuretic and a beta-adrenergic blocker. In a double-blind, randomized crossover trial the subjects received weekly increments of placebo or nitroglycerin (5, 10, 20, and ...
G, Simon, V J, Wittig, J N, Cohn
openaire   +3 more sources

Adhesive Matrix Type Transdermal Drug Delivery System for Nitroglycerin

Drug Development and Industrial Pharmacy, 1994
AbstractThe kinetics of release of nitroglycerin from adhesive matrix type patches was studied. At a high drug to adhesive ratio the patch consisted of nitroglycerin in part dispersed as droplets in the adhesive and in part dissolved in the adhesive.
Rajesh M. Pai, Meenal S. Desai, Asph D. Babtiwale, R. Shrivastava   +3 more
openaire   +2 more sources

Absence of Drug Interaction Between Heparin and Nitroglycerin

Archives of Internal Medicine, 1990
The purpose of this randomized crossover study was to determine whether nitroglycerin interacts with heparin in terms of its anticoagulative properties as determined by activated partial thromboplastin time and thrombin time. Eight healthy adults were given either a 60-minute intravenous infusion of 5 mg of nitroglycerin or a 0.9% sodium chloride ...
Volker Bode
openaire   +2 more sources